Two Sigma Securities, LLC Timber Pharmaceuticals, Inc. Transaction History

Two Sigma Securities, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.1 - $0.3 $27,838 - $83,514	278,382 Added 588.81%	325,661 $39,000
Q2 2022 Aug 15, 2022	BUY	$0.24 - $0.39 $8,579 - $13,941	35,748 Added 310.02%	47,279 $15,000
Q1 2022 May 16, 2022	BUY	$0.28 - $0.41 $3,228 - $4,727	11,531 New	11,531 $4,000
Q4 2021 Feb 14, 2022	SELL	$0.38 - $0.89 $6,137 - $14,374	-16,151 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$0.89 - $1.18 $14,374 - $19,058	16,151 New	16,151 $15,000
Q1 2021 May 17, 2021	SELL	$0.81 - $3.55 $14,238 - $62,401	-17,578 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$0.72 - $1.52 $12,656 - $26,718	17,578 New	17,578 $13,000

Ticker TMBR
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 146,524,992
Description
Timber Pharmaceuticals LLC, a clinical-stage biopharmaceutical company, engages in the development and commercialization of treatments for orphan dermatologic diseases. The company's lead product candidates include TMB-001, a patented topical formulation of isotretinoin that has completed Phase 2b clinical trial for the treatment of moderate to ...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.